Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
7(35%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
3
15%
Ph not_applicable
8
40%
Ph phase_1
2
10%
Ph phase_2
3
15%
Ph phase_3
2
10%

Phase Distribution

5

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution18 total trials
Early Phase 1First-in-human
3(16.7%)
Phase 1Safety & dosage
2(11.1%)
Phase 2Efficacy & side effects
3(16.7%)
Phase 3Large-scale testing
2(11.1%)
N/ANon-phased studies
8(44.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

20

all time

Status Distribution
Active(9)
Completed(6)
Other(5)

Detailed Status

Completed6
unknown5
Recruiting4
Active, not recruiting3
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
7
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 13 (16.7%)
Phase 12 (11.1%)
Phase 23 (16.7%)
Phase 32 (11.1%)
N/A8 (44.4%)

Trials by Status

not_yet_recruiting15%
unknown525%
enrolling_by_invitation15%
completed630%
active_not_recruiting315%
recruiting420%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07172191Not Applicable

Fecal Microbiota Transplantation Among Adult Patients With Hematological Malignancies

Enrolling By Invitation
NCT07375797Not Applicable

Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes

Active Not Recruiting
NCT07509346Phase 2

Fecal Microbiota Transplant vs Standard Treatment for Recurrent Non-Obstructive Cholangitis

Not Yet Recruiting
NCT07223606

Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

Unknown
NCT06890650Not Applicable

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease

Recruiting
NCT06890637Not Applicable

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Disease on Advanced Therapies

Recruiting
NCT06895252Not Applicable

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis

Recruiting
NCT06906445Not Applicable

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies

Recruiting
NCT03772899Phase 1

Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)

Active Not Recruiting
NCT06697119Not Applicable

Efficacy and Safety of Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome

Active Not Recruiting
NCT02326636

Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection

Completed
NCT04758806Phase 3

Fecal Microbial Transplantation in Severe Alcoholic Hepatitis

Unknown
NCT04283968Phase 3

Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis

Unknown
NCT03268213Early Phase 1

Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis

Completed
NCT03267238Early Phase 1

Fecal Microbial Transplantation in Patients With Crohn's Disease

Completed
NCT04613037Early Phase 1

Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis

Completed
NCT03876327Phase 2

Fecal Microbiota Transplantation As a Potential Treatment for Parkinson's Disease

Completed
NCT04336319Phase 2

Fecal Microbial Transplantation for Ileal Pouch Anal Anastomosis Patients

Unknown
NCT04328922Not Applicable

Fecal Microbial Transplantation and Vedolizumab Treatment of Crohn's Disease

Unknown
NCT01847170Phase 1

Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease

Completed

All 20 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
20